Integrative Care for Type 2 Diabetes

Inclusion Criteria: * Males or females, enrolled as a patient with WE-FHT * Ages 21-75 years old * Diagnosed with type 2 diabetes and not adequately controlled (HbA1c \> 7.0mmol/L) * Currently seeking care with a medical doctor, nurse practitioner and/or physician assistant * Willingness to adhere to randomized treatment with availability for follow-up * Ability to answer self- and interviewer- administered questions in English or have an English speaking caregiver who can aid in answering self- and interviewer- administered questions * Ability to provide written informed consent or give informed consent through substitute decision maker * Capacity to maintain a diary and log of treatments and recommendations given during study Exclusion Criteria: * Lacking capacity for consent * Pregnancy or an intention to become pregnant in the following two years * Breastfeeding * History of myocardial infarction within the past 6 months * Chronic kidney (eGFR \<30 mL/min) or liver disease * Actively receiving care from a complex care diabetes clinic * History of severe hypoglycemia in the last year resulting in hospital emergency care \[where hypoglycemia is defined to be: 1) development of autonomic or neuroglycopenic symptoms, 2) low plasma glucose level (\<4.0mmol/L for patients treated with insulin or an insulin secretagogue) and 3) symptoms responding to the administration of carbohydrate\] or hypoglycemia unawareness * Current bolus or pre-mixed insulin treatment * Limited life expectancy (\< 6 months) * High level of functional dependency (inability to perform common activities of daily living) * In participants aged 65yoa to 75yoa, the following also serve as exclusion criteria: 1. Recent MI or stroke (within last 6 months) 2. NYHA CHF Functional Capacity Stage III or above 3. NYHA CHF Objective Assessment Stage C or greater (http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure\_UCM\_306328\_Article.jsp) 4. Planned revascularization procedure (PCI or coronary artery bypass graft) or coronary angiogram within 90 days after screening or randomization